Dr Agarwal'S Eye Hospital (BOM:526783) Cash Flow for Dividends: ₹0 Mil (TTM As of Mar. 2026)


BOM:526783 Dr Agarwal'S Eye Hospital Ltd BOM:526783
94 GF Score
Price ₹5,099.95
GF Value ₹5,310.81
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr Agarwal'S Eye Hospital Cash Flow for Dividends?

Dr Agarwal'S Eye Hospital BOM:526783 +2.10% 94 Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:526783 with a GF Score™ of 94/100 and a GF Value™ of ₹5,310.81 (Fairly Valued). The stock has 3 warning signs investors should review.

Dr Agarwal'S Eye Hospital's cash flow for dividends for the three months ended in Mar. 2026 was ₹0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Dr Agarwal'S Eye Hospital's annual payment of dividends declined from Mar. 2024 (₹-26 Mil) to Mar. 2025 (₹-24 Mil) but then increased from Mar. 2025 (₹-24 Mil) to Mar. 2026 (₹-31 Mil).

Dr Agarwal'S Eye Hospital Cash Flow for Dividends Related Terms

Dr Agarwal'S Eye Hospital Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Dr Agarwal'S Eye Hospital's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Agarwal'S Eye Hospital Cash Flow for Dividends Chart

Dr Agarwal'S Eye Hospital Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.20 -14.10 -25.80 -23.50 -30.90

Dr Agarwal'S Eye Hospital Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:526783
94GF Score
Dr Agarwal'S Eye Hospital Ltd BOM:526783
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Agarwal'S Eye Hospital Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0 Mil mean?
Dr Agarwal'S Eye Hospital (BOM:526783) has a Cash Flow for Dividends of ₹0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Dr Agarwal'S Eye Hospital and its competitors.
Is Dr Agarwal'S Eye Hospital's Cash Flow for Dividends too high?
Dr Agarwal'S Eye Hospital's current Cash Flow for Dividends is ₹0 Mil. Overall, Dr Agarwal'S Eye Hospital has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal'S Eye Hospital's Cash Flow for Dividends compare to HCA and THC?
Dr Agarwal'S Eye Hospital's Cash Flow for Dividends of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Dr Agarwal'S Eye Hospital and its competitors. Dr Agarwal'S Eye Hospital's current Cash Flow for Dividends is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal'S Eye Hospital stock overvalued right now?
Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital (BOM:526783) is currently considered Fairly Valued. The stock's GF Value™ is ₹5,310.81, compared to a current price of ₹5,099.95 — trading 4% below its estimated fair value. The current Cash Flow for Dividends is ₹0 Mil. Dr Agarwal'S Eye Hospital's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Dr Agarwal'S Eye Hospital (BOM:526783), the current Cash Flow for Dividends is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Agarwal'S Eye Hospital (BOM:526783) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Agarwal'S Eye Hospital stock appears to be undervalued. The current stock price of ₹5,099.95 is trading 4% below its estimated GF Value™ of ₹5,310.81. GuruFocus considers Dr Agarwal'S Eye Hospital to be Fairly Valued.

Key valuation signals for BOM:526783:

  • Cash Flow for Dividends: ₹0 Mil
  • GF Value™: ₹5,310.81 vs. price of ₹5,099.95 (4% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the BOM:526783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr Agarwal'S Eye Hospital Business Description

Address No. 4, Moores Road, Off Greams Road, 3rd Floor, Buhari Towers, Chennai, TN, IND, 600 006
Dr Agarwal'S Eye Hospital Ltd is a provider of eye care and related services. The company is predominantly engaged in running, owning and managing eye care hospitals, opticals, pharmacies, and related services. It operates across various locations in India and provides solutions like Refractive Surgery, Lasik Surgery, Oculoplasty, Laser Cataract Surgery, and SMILE Eye Surgery among others.
94GF Score

Get the complete analysis for BOM:526783

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,099.95
Price
₹5,310.81
GF Value